These time limits typically range from one to three years from the date of injury discovery, though some states have specific statutes for pharmaceutical cases
8994, Apr
However, its relatively short plasma half-life of 23 min, due to rapid degradation by dipeptidyl peptidase-4 (DPP-4), has prompted structural modifications to enhance its pharmacological efficacy
To see the best response to a GLP-1 medication, patients should generally follow the six pillars of Lifestyle Medicine, Glickman says
Providing an energy boost
Last month (May 2025), Novo Nordisk and Septerna, a San Francisco, California-based bio/pharmaceutical company focused on GCPRs, formed an exclusive global collaboration and license agreement to discover, develop, and commercialize oral small-molecule medicines for treating obesity, Type 2 diabetes, and other cardiometabolic diseases, in a deal worth up to $2.2 billion ($200 million upfront and near-term funding and $2 billion in milestone payments)